Anchiano Therapeutics Ltd. ANCN
$ 4.71
5.37%
Country |
Israel |
IPO year |
2019 |
Industry |
- |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Frank G. Haluska |
Employees in the company |
16 |
Shares |
- |
Market Cap[1] |
$ 34.9 M |
EBITDA (LTM) |
$ -57.1 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.